Northern Trust Company of Connecticut’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BIT
Northern Trust Company of Connecticut's ALXN Position: Q4 2013 in Review
Northern Trust Company of Connecticut increased its Alexion Pharmaceuticals (ALXN) stake by 21% in Q4 2013, buying an estimated $5.92M and bringing the position to 279,003 shares worth $37.1M. The position accounts for 0.23% of the portfolio, ranked #84.
Northern Trust Company of Connecticut first reported a position in ALXN in Q2 2013 and has held it in 3 quarters since. 463 funds tracked by Wall St. Rank hold ALXN as of Q4 2013.
- Northern Trust Company of Connecticut held 279,003 shares of Alexion Pharmaceuticals worth $37.1M as of Q4 2013.
- Northern Trust Company of Connecticut bought 49,347 Alexion Pharmaceuticals shares in Q4 2013, an estimated $5.92M.
- Alexion Pharmaceuticals made up 0.23% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #84 holding.
- Northern Trust Company of Connecticut first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
- 463 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2013.
Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.